| |
Type |
 G Protein-coupled receptors
|
|
|
Ion channels
|
|
|
Nuclear receptors
|
|
|
 Protein kinases
|
Serine/threonine kinases
|
AGC group
|
CAMK group
|
CMGC group
|
STE group
|
TKL group
|
Other
|
IKBKB [HSA:3551] [KO:K07209]
|
PLK1 [HSA:5347] [KO:K06631]
|
MTOR [HSA:2475] [KO:K07203]
|
 D06068 Temsirolimus (JAN/USAN/INN) <JP/US>
D02714 Everolimus (JAN/USAN/INN) <JP/US>
D08900 Ridaforolimus (JAN/USAN)
D00753 Sirolimus (JAN/USAN/INN) <JP/US>
D06669 Zotarolimus (USAN/INN)
D10076 Olcorolimus (USAN)
D10543 Apitolisib (USAN/INN)
D10552 Dactolisib (USAN/INN)
D10616 Dactolisib tosylate (USAN)
D10635 Gedatolisib (USAN/INN)
D10718 Omipalisib (USAN/INN)
D11440 Bimiralisib (USAN/INN)
D11501 Samotolisib (USAN)
D11663 Onatasertib (USAN)
D11727 Voxtalisib (USAN/INN)
D11869 Paxalisib (USAN/INN)
|
|
PDK [HSA:5164 5165 5166] [KO:K00898]
|
ATR [HSA:545] [KO:K06640]
|
WEE1 [HSA:7465] [KO:K06632]
|
BRD2 [HSA:6046] [KO:K08871]
|
BRD3 [HSA:8019] [KO:K11721]
|
BRD4 [HSA:23476] [KO:K11722]
|
BRDT [HSA:676] [KO:K11724]
|
Receptor serine/threonine kinases (RSTK)
|
Receptor tyrosine kinases (RTK)
|
Non-receptor tyrosine kinases
|
|
|
Cytokines and receptors
|
|
|
Cell surface molecules and ligands
|
|
|
Transporters
|
|
|
Enzymes
|
|
|
Nucleic acids
|
|
|
Not elsewhere classified
|
Target-based Classification of Drugs